Cancer immunotherapy is an advanced treatment approach that helps the body's immune system recognize and attack cancer cells more effectively. Unlike traditional treatments that directly target cancer, immunotherapy strengthens or modifies the immune response to fight the disease. It has become an important treatment option for several types of cancer and continues to expand as research advances. While not suitable for every patient or every cancer type, immunotherapy has improved outcomes for many individuals with certain cancers.
The immune system naturally detects and destroys abnormal cells. However, some cancer cells develop ways to avoid immune detection.
Immunotherapy works by:
The specific type of immunotherapy depends on the type of cancer and its biological characteristics.
Several forms of immunotherapy are used in cancer treatment, including:
Not every treatment is appropriate for every cancer or every patient.
Immunotherapy is used for a growing number of cancers, including:
Eligibility depends on cancer type, stage, and molecular testing results.
Before starting immunotherapy, healthcare providers may recommend:
These evaluations help determine whether immunotherapy is likely to be beneficial.
Potential benefits may include:
Treatment outcomes vary depending on the type of cancer and individual response.
Because immunotherapy activates the immune system, side effects can occur when healthy tissues are affected.
Possible side effects include:
Many side effects can be managed effectively when identified early.
Regular follow-up helps evaluate treatment response and detect side effects.
Monitoring may include:
Routine monitoring allows healthcare providers to adjust treatment when necessary.
Prompt medical evaluation is recommended if symptoms include:
Early recognition and treatment of immune-related side effects are important.
Cancer immunotherapy has transformed the treatment of many cancers by helping the immune system recognize and destroy cancer cells. Advances in checkpoint inhibitors, CAR T-cell therapy, monoclonal antibodies, and other immunotherapies continue to improve outcomes for selected patients. Careful patient selection, regular monitoring, and individualized treatment planning are essential to maximize the benefits of immunotherapy while managing potential side effects.